english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Lack of access to drug evaluation data: a recurrent problem, not confined to covid-19

Dabrafenib (Tafinlar°) and trametinib (Mekinist°) combined, as adjuvant therapy for stage III melanoma with a BRAF V600 mutation

In the June issue of Prescrire International: Antispasmodics during pregnancy, in brief

Curiosity is an admirable quality

Drug-induced heart valve disease: a blind spot for cardiologists

Prescrire: independence and transparency, in the name of better patient care

Tramadol: an opioid analgesic to be used with caution

Thyroid hormone treatment: no proof of benefit in asymptomatic subclinical hypothyroidism

Measles-mumps-rubella vaccine (MMR): no link with autism

In the May issue of Prescrire International: Dulaglutide (Trulicity°) and type 2 diabetes. No reduction in all-cause mortality or cardiovascular mortality

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90